New CEO at Celltech Medeva

Simon Cartmell was appointed CEO of the Celltech Medeva business, which is being acquired by PowderJect (LSE:PJP) (see BioCentury Extra, Thursday Sept. 7). Cartmell, who had been COO of Vanguard Medi...